BUGLIONE DI MONALE E BASTIA, Michela
 Distribuzione geografica
Continente #
NA - Nord America 9.044
EU - Europa 3.551
AS - Asia 1.735
AF - Africa 16
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 10
Totale 14.386
Nazione #
US - Stati Uniti d'America 9.016
CN - Cina 1.047
UA - Ucraina 979
DE - Germania 603
PL - Polonia 562
IT - Italia 518
HK - Hong Kong 334
FI - Finlandia 256
SG - Singapore 185
IE - Irlanda 182
GB - Regno Unito 165
FR - Francia 130
VN - Vietnam 52
IN - India 44
RU - Federazione Russa 43
CZ - Repubblica Ceca 29
SE - Svezia 28
TR - Turchia 27
CA - Canada 24
BE - Belgio 16
EU - Europa 14
AU - Australia 10
NL - Olanda 10
BR - Brasile 8
IR - Iran 8
JP - Giappone 8
GR - Grecia 6
ID - Indonesia 6
AR - Argentina 4
MA - Marocco 4
AT - Austria 3
BD - Bangladesh 3
BY - Bielorussia 3
EG - Egitto 3
IL - Israele 3
MU - Mauritius 3
TN - Tunisia 3
TW - Taiwan 3
CH - Svizzera 2
EC - Ecuador 2
HU - Ungheria 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NO - Norvegia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SL - Sierra Leone 2
SV - El Salvador 2
TH - Thailandia 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 14.386
Città #
Fairfield 1.304
Woodbridge 1.085
Ashburn 792
Jacksonville 724
Houston 678
Seattle 562
Warsaw 560
Cambridge 538
Chandler 535
Ann Arbor 495
Wilmington 470
Princeton 337
Hong Kong 331
New York 247
Nanjing 211
Beijing 186
Dublin 182
Dearborn 178
Helsinki 155
Singapore 116
Brescia 95
Nanchang 87
Shanghai 79
San Diego 71
Des Moines 70
Milan 62
Changsha 54
Dong Ket 52
Shenyang 50
Hebei 49
Jinan 47
Washington 43
Boardman 41
Tianjin 38
Jiaxing 36
Kunming 34
Brno 26
London 26
Hangzhou 25
San Francisco 23
Lancaster 22
Ningbo 21
Kocaeli 18
Toronto 17
Zhengzhou 17
Brussels 16
Ceto 16
Los Angeles 16
Haikou 15
Nürnberg 15
Taizhou 15
Verona 15
Munich 13
Norwalk 13
Redwood City 12
Rome 12
Guangzhou 11
Lanzhou 11
Orange 10
Pune 10
Changchun 9
Dresden 8
Iseo 8
Kilburn 8
San Mateo 8
Vignate 8
Hefei 7
Athens 6
Phoenix 6
Cazzago San Martino 5
Hounslow 5
Leawood 5
Monza 5
New Bedfont 5
North York 5
Tokyo 5
Amsterdam 4
Ardabil 4
Augusta 4
Chiswick 4
Chongqing 4
Cremona 4
Delhi 4
Falls Church 4
Fuzhou 4
Gunzenhausen 4
Melbourne 4
Sydney 4
Taiyuan 4
Treviglio 4
Westminster 4
Albano Laziale 3
Bologna 3
Buenos Aires 3
Castiglione Delle Stiviere 3
Chengdu 3
Chicago 3
Dhaka 3
Florence 3
Frankfurt am Main 3
Totale 11.179
Nome #
Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma 213
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 205
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 200
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 192
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 177
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 156
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 152
Pros-IT CNR: an Italian prostate cancer monitoring project 147
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 144
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 143
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 142
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 140
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 140
Radiotherapy in patients with HIV: current issues and review of the literature 140
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 139
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 136
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 135
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 135
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 130
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 129
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 129
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 127
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 126
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 124
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 122
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 121
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 120
Role of external beam radiotherapy in the treatment of relapsing meningioma 120
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 119
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 119
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 117
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 114
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 114
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 113
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 112
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 111
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 110
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 110
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 110
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 109
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 109
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 109
Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection? 109
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 108
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 108
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 108
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 108
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 107
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 107
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 106
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 105
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 105
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 105
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 104
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 104
From Molecular to Clinical Radiation Biology of Glioblastoma 104
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 104
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 103
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 103
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 102
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 102
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 101
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 100
Information Retrieval in Medicine: an Extensive Experimental Study 98
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 96
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 93
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 93
Nasopharyngeal carcinoma 92
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 92
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 91
Cetuximab and Radiation Therapy in Head and Neck Cancer 91
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 90
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 90
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 90
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 89
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 89
Letter to “Medial lingual lymph node metastasis in carcinoma of the tongue” 89
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 87
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 86
Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. 86
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 86
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 86
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 86
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 84
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 84
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 84
Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis. 83
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 83
Practical prognostic score for predicting the extent of resection and neurological outcome of gliomas in the sensorimotor area 83
Post-ABVD/pre-radiotherapy 18F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: A retrospective analysis on 165 patients 83
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 82
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). 81
Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO) 80
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. 78
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 77
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 76
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 76
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 75
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 75
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 75
Totale 11.022
Categoria #
all - tutte 68.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.943 475 135 142 414 235 510 417 442 305 499 139 230
2020/20212.932 79 282 136 327 151 357 113 316 320 394 262 195
2021/20221.355 110 197 38 58 16 75 54 113 75 161 86 372
2022/20231.362 188 88 47 103 126 339 6 138 214 17 53 43
2023/20241.813 87 32 192 94 97 413 64 80 350 53 79 272
2024/202529 29 0 0 0 0 0 0 0 0 0 0 0
Totale 14.790